NCT00344188
Diagnosis and Treatment of Leishmania Infections No drug interventions Not Available Not Available recruiting NCT02429505
Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Not Available Not Available withdrawn NCT02656797
Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis treatment 2 completed NCT03294161
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis treatment 2 completed NCT03993093
Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre No drug interventions Not Available Not Available completed NCT06307171
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers No drug interventions diagnostic Not Available recruiting NCT01300975
Intralesional Antimony for Bolivian Cutaneous Leishmaniasis treatment 2 completed NCT04512742
A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies No drug interventions other Not Available completed NCT00401349
Expression of Mif Alleles in Individuals With Leishmaniasis No drug interventions Not Available Not Available completed NCT00657618
Use of Sodium Stibogluconate as a Treatment for Leishmaniasis treatment 1 / 2 completed NCT03874234
Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects No drug interventions treatment 1 terminated NCT03641339
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans No drug interventions basic_science Not Available completed NCT00401557
Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection No drug interventions Not Available Not Available completed NCT01377974
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis treatment 2 completed NCT01437020
SCH708980 With and Without AmBisome for Visceral Leishmaniasis treatment 1 / 2 withdrawn NCT00373776
Miltefosine for Mucosal Leishmaniasis treatment 1 / 2 completed NCT06124144
Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults treatment 1 terminated NCT00662012
Sodium Stibogluconate Treatment of Leishmaniasis treatment 2 completed NCT00401297
Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes No drug interventions Not Available Not Available completed NCT02530697
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil treatment 2 active_not_recruiting NCT05449717
Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan No drug interventions Not Available Not Available recruiting NCT04504435
Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants No drug interventions treatment 1 completed NCT03009422
Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis. treatment Not Available unknown_status NCT01751048
LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine prevention 1 completed NCT03784248
Mediterranean Visceral Leishmaniasis With Leishmania Infantum No drug interventions Not Available Not Available recruiting NCT01484548
Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers prevention 1 completed NCT00373568
Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis treatment 1 / 2 completed NCT00001169
Clinical Investigation of Infections Due to Leishmanial Parasites No drug interventions Not Available Not Available completed NCT00004755
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil treatment 2 completed